Emperra’s ESYSTA Bluetooth Pen is a sophisticated diabetes device that is connected to a smartphone-enabled insulin app. The gadget's convenient mobile platform makes monitoring blood sugar levels easy for those suffering from diabetes.
Currently in development across Europe, this insulin app is comprehensive and easy to use, especially for those who are tech-savvy and likely to keep track of health and fitness activities on their smartphone.
The Emperra ESYSTA bluetooth pen and insulin app system boasts a sleek and intuitive interface that helps users track and monitor blood sugar levels, physical activity and overall health with the touch of a screen. As society becomes more connected, disease management is becoming more convenient and hassle-free for those dealing with mentally and physically grueling health conditions.
What's Driving This Trend
- Smartphone Diabetes Management
- The Emperra ESYSTA bluetooth pen and insulin app system offers an innovative solution for smartphone diabetes management with its intuitive interface.
- Connected Health Apps
- The popularity of smartphone-enabled health management apps is rapidly growing which presents an opportunity for connected health app developers to design innovative apps for diabetes management and prevention.
- Internet of Medical Things
- The use of connected medical devices is a growing trend that drives the development of the Internet of Medical Things, creating new opportunities for medical device manufacturers.
Who This Affects Most
- Healthcare and Medical Devices
- The use of connected medical devices and related smartphone apps for disease management is changing the healthcare industry and opening up new opportunities for medical device manufacturers and developers.
- Mobile App Development
- There is an increasing demand for the development of connected health apps which is leading to growth opportunities in the mobile app development industry.
- Patient Monitoring and Disease Management
- Connected health devices are changing the way patients manage their disease creating opportunities for improving patient monitoring and disease management.
